Immunome (IMNM) Net Margin (2023 - 2025)
Immunome's (IMNM) quarterly Net Margin came in at 1751.01% in Q2 2025, up 189650.0% YoY from N/an in Q2 2024, and down 14.11% on a QoQ basis from 1534.52% in Q1 2025.
Analysis
Immunome (IMNM) Net Margin (2023 - 2025) Analysis & Trends
Immunome (IMNM) has 3 years of Net Margin data on file, last reported at 1751.01% in Q2 2025.
- Quarterly Net Margin rose 189650.0% year-over-year to 1751.01% in Q2 2025, while the trailing twelve-month figure through Mar 2026 was 12187.25% (down 916542.0% YoY) and the FY2025 annual result came in at 5831.74%, down 126897.0% from the prior year.
- Net Margin eased to 1751.01% in Q2 2025, from 1534.52% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 121.88% in Q3 2023 to a low of 12866.76% in Q1 2024.
- A 3-year average of 2994.53% and a median of 2086.09% in 2023 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2024 — Net Margin plunged 1267341 bps — and 2025, when it jumped 1133225 bps.
- Tracing IMNM's Net Margin over 3 years: stood at 2421.17% in 2023, then dropped by 26 bps to 3041.27% in 2024, then jumped by 42 bps to 1751.01% in 2025.
- The last three Net Margin figures came in at 1751.01% (Q2 2025), 1534.52% (Q1 2025), and 3041.27% (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -539.31% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 13.90% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 12.74% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 12.09% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -3.12% |
| 10 | Immunome | 3.03 Bn | 2.51 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -1,157.61% |
| Mar 31, 2025 | -1,525.50% |
| Dec 31, 2024 | -3,030.31% |
| Sep 30, 2024 | -1,736.15% |
| Jun 30, 2024 | -1,692.43% |
| Mar 31, 2024 | -12,857.05% |
| Dec 31, 2023 | -2,421.17% |
| Sep 30, 2023 | -121.88% |
| Jun 30, 2023 | -135.42% |
| Mar 31, 2023 | -189.13% |